Trend Results : Rome


Related Searches

Blog Results (1)

Blog Post Results (1-20 of 10000+)

FILTER RESULTS

Britannia #1

Visit the ancient pagan lands of Rome's bloodied empire in Valiant's "Britannia" #1 by Peter Milligan and Juan Jose Ryp. The post Britannia #1 appeared first on CBR.com.

Mark Zuckerberg & Wife Priscilla Tour Rome After Meeting Pope Francis

Facebook founder Mark Zuckerberg and his wife Priscilla step out to check out the sights on Monday (August 29) in Rome, Italy. “We had a great time in Rome and wrapped with a visit to the Colosseum last night. Thanks to everyone we met and who has been so welcoming. We’ll be back soon!” Mark [...]

Italy rescues 3,000 migrants from Mediterranean as arrivals surge

ROME (Reuters) - Some 3000 migrants were saved in the Strait of Sicily in 30 separate rescue missions on Tuesday, the Italian coastguard said, bringing the total to almost 10,000 in two days and marking a sharp acceleration in refugee arrivals in Italy.

After 400 Years, Giordano Bruno Is Still A Free-Speech Hero

9 hours agoArts : Modern Art Notes

“Go to Campo dei Fiori in Rome on 17 February and you will find yourself surrounded by a motley crowd of atheists, pantheists, anarchists, Masons, mystics, Christian reformers and members of the Italian Association of Free Thinkers … In the four centuries since he was executed for heresy by the Roman Inquisition, this diminutive iconoclast […]

Mark Zuckerberg -- When In Rome ... I Mingle (PHOTOS)

10 hours agoPop Culture / Celebrity : TMZ.com

Mark Zuckerberg and wife Priscilla Chan were just two regular tourists Monday night roaming around the Colosseum in Rome... with nearly $52 billion rattling around in their pockets. The couple got chatty with the non-billionaires…

Why Pope Francis may be meeting with so many tech CEOs

On Monday, the Bishop of Rome met with one of the high priests of Silicon Valley. During a trip to Italy, Mark Zuckerberg attended the wedding of a friend, went for a run past the Colosseum, hosted a Q&A session -- oh, and met with the Pope. At the Vatican on Monday, the Facebook founder and CEO, along with his wife, […]

OPTICARE trial: Enhanced cardiac rehab programs help heart attack patients

Rome, Italy - 29 Aug.2016: Enhanced cardiac rehabilitation (CR) programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard 3-month program in patients recovering from a heart attack. read more

SAVE: Sleep apnea treatment: No cardiovascular benefit

Rome, Italy- 28 August 2016: More than 3 years of nightly treatment with a continuous positive airway pressure (CPAP) machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive...Show More Summary

DANISH: No overall survival benefit with ICDs in non-ischemic heart failure

Rome, Italy - 28 August, 2016: Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care - although a secondary outcome, risk of sudden cardiac death, was halved with ICD placement, according to new research reported here. read more

The REM-HF trial: Remote monitoring of implantable cardiac devices: No added benefit

Rome, Italy - 28 August, 2016: For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented...Show More Summary

MORE-CARE: No clinical benefit for cardiac device remote monitoring

Rome, Italy - 28 August, 2016: Heart failure patients fitted with biventricular defibrillators (CRT-D) fared no better with remote monitoring (RM) of their condition compared to those whose devices were monitored during in-clinic visits, according to results of the MORE-CARE study. read more

CHART-1: Largest cardiac regenerative therapy trial brings new insights

Rome, Italy - 28 August, 2016: A therapy that uses bone-marrow stem cells to promote heart repair did not significantly improve the primary outcome over a sham procedure among patients with congestive heart failure. However, it revealed critical new insights, according to investigators of the CHART-1 trial. read more

Infused stem cells in heart failure: Improved health status but not cardiac function

Rome, Italy - 28 August, 2016: A single dose of mesenchymal stem cells delivered intravenously to patients with chronic non-ischemic cardiomyopathy was not associated with significant cardiac structural or functional improvements, but did result in several clinically relevant benefits, according to results from a phase II-a randomized trial. read more

Mark Zuckerberg: Facebook Won’t Become A Media Company

Media moguls can relax, a little, about the possibility of having to compete against Facebook. The social media giant is “a tech company, not a media company,” CEO Mark Zuckerberg  told a student gathering today in Rome, where he visited...Show More Summary

ODYSSEY ESCAPE: Alirocumab cuts apheresis rates in familial hypercholesterolemia

Rome, Italy - 29 August 2016: Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can...Show More Summary

Lipoprotein apheresis: A new approach to refractory angina?

Rome, Italy - 29 August, 2016: Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in patients with refractory angina. New results...Show More Summary

First European standards for management of heart attack patients launched today

Rome, Italy - 29 August 2016: The first European standards for the management of heart attack patients are launched today by the European Society of Cardiology-Acute Cardiac Care Association (ESC-ACCA). The quality indicators for acute...Show More Summary

HIJ-PROPER trial -- Intensive cholesterol-lowering treatment: No significantly better outcomes

Rome, Italy - 29 August 2016: Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin treatment alone in patients with acute coronary syndrome (ACS) and dyslipidemia, investigators reported here. read more

AMERICA: No benefit to detecting and treating extra-coronary lesions

Rome, Italy - 29 August, 2016 : In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve...Show More Summary

CE-MARC 2: Pointing the way to fewer invasive angiograms

Rome, Italy - 29 August, 2016: Initial investigation of patients with suspected coronary heart disease (CHD) using functional imaging - rather than guideline-directed care - resulted in significantly less unnecessary angiography, according to results of the CE-MARC 2 trial. read more

Copyright © 2015 Regator, LLC